GMED Globus Medical, Inc. Class A Common Stock
$88,21
Kurs · Aug 20, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$54–$101
72% of range
Analystenbewertung
BUY
23 analysts
Kursziel
$103
+17% upside
P/E (TTM)
22.3
ROE
12.1%
Nettogewinnmarge
18.3%
Über Globus Medical, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Mehr lesen
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
GMED Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$88.21
Marktkapitalisierung
—
P/E (TTM)
22.3
EPS (TTM)
$3.92
Umsatz (TTM)
$2.94B
Dividendenrendite
—
ROE
12.1%
Verschuldungsgrad
—
52W-Spanne
$54 – $101
GMED Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$2.94B
2016-12-31
→
2025-12-31
EPS
$3.92
2016-12-31
→
2025-12-31
Freier Cashflow
$589M
2016-12-31
→
2025-12-31
Margen
18.3%
2016-12-31
→
2023-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
GMED
Peer-Median
P/E (TTM)
22.3
27.5
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
GMED
Peer-Median
Operating Margin (Betriebsgewinnmarge)
16.3%
—
Net Profit Margin (Nettogewinnmarge)
18.3%
9.8%
ROA
10.2%
5.1%
ROE
12.1%
8.6%
ROIC
9.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
GMED
Peer-Median
Current Ratio (Liquiditätsgrad)
4.3
2.7
Quick Ratio
2.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
GMED
Peer-Median
Revenue YoY (Umsatz YoY)
16.7%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
42.2%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
30.1%
—
EPS YoY (EPS VjV)
422.7%
—
Net Income YoY (Nettogewinn YoY)
422.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
GMED
Peer-Median
GMED Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
23 Analysten
- Starker Kauf 4 17,4%
- Kauf 12 52,2%
- Halten 7 30,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-08-15
Median
$100.00
Jetzt
$88.21
Tief
$84.00
Hoch
$125.00
Median-Ziel
$100.00
+13,4%
Mittelwert-Ziel
$103.23
+17,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.15%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $1.34 | $1.12 | 0.22% |
| 31. März 2026 | $1.12 | $0.94 | 0.18% |
| 31. Dezember 2025 | $1.28 | $1.17 | 0.11% |
| 30. September 2025 | $1.18 | $0.80 | 0.38% |
| 30. Juni 2025 | $0.86 | $0.77 | 0.09% |
| 31. März 2025 | $0.68 | $0.76 | -0.08% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GMED | — | 22.3 | 16.7% | 18.3% | 12.1% | — |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | — | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
Wachstumsraten 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | -271,249,000 | 134,502,000 | 135,205,000 | 136,757,000 | -270,442,000 | 135,615,000 | 135,195,000 | 135,358,000 | -201,102,000 | 113,537,000 | 100,373,000 | 100,279,000 | -201,454,000 | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | -274,611,000 | 135,394,000 | 136,499,000 | 139,774,000 | -272,536,000 | 138,062,000 | 136,979,000 | 135,358,000 | -204,593,000 | 115,245,000 | 101,782,000 | 102,196,000 | -205,735,000 | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
Cashflow 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
Bewertung (TTM) 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.06B | $2.87B | · | $2.74B | $2.60B | $2.46B | · | $2.25B | $1.91B | $1.56B | · | $1.21B | $1.09B | $1.03B | · | $978M | |
| Net Income TTM | $598M | $522M | · | $449M | $362M | $152M | · | $77M | $83M | $101M | · | $155M | $209M | $189M | · | $187M | |
| P/E | 18.1 | 22.6 | · | 17.4 | 22.4 | 66.5 | · | 125.5 | 90.1 | 53.1 | · | 32.5 | 29.0 | 30.6 | · | 32.7 | |
| Earnings Yield | 5.5% | 4.4% | · | 5.7% | 4.5% | 1.5% | · | 0.80% | 1.1% | 1.9% | · | 3.1% | 3.4% | 3.3% | · | 3.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| Bruttogewinnmarge % | — | — | 65.0% | — | 75.0% |
| Betriebsgewinnmarge % | 16.3% | 6.6% | 8.5% | — | 17.9% |
| Nettoergebnis | $538M | $103M | $123M | $190M | $149M |
| Verwässerte EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.3 | 2.5 | 4.9 | — | 6.2 |
| Quick Ratio | 2.5 | 0.8 | 1.4 | — | 3.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $589M | $405M | $165M | — | $219M |
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 642 Einreicher · $5.7B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 76 (-40 vs. Vorquartal) | 82 (+32 vs. Vorquartal) | 246 (+26 vs. Vorquartal) | 176 (-6 vs. Vorquartal) | +453K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $403.546.103 | 5.107.532 | 7,04% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394.606.359 | 4.994.385 | 6,89% | Aktien |
| STATE STREET CORP | $293.540.630 | 3.714.029 | 5,12% | Aktien |
| Sculptor Capital LP | $237.030.000 | 3.000.000 | 4,14% | Aktien |
| Burgundy Asset Management Ltd. | $212.054.428 | 3.460.983 | 3,70% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $205.090.439 | 2.380.344 | 3,58% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $166.610.599 | 2.108.728 | 2,91% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135.630.225 | 1.716.621 | 2,37% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $134.690.079 | 1.704.191 | 2,35% | Aktien |
| Boston Partners | $112.054.767 | 1.418.394 | 1,96% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101.519.633 | 1.284.896 | 1,77% | Aktien |
| Quantinno Capital Management LP | $96.320.933 | 1.219.098 | 1,68% | Aktien |
| NORGES BANK | $89.048.300 | 1.127.051 | 1,55% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88.055.393 | 1.114.484 | 1,54% | Aktien |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88.048.981 | 1.114.403 | 1,54% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84.736.329 | 1.072.476 | 1,48% | Aktien |
| GENEVA CAPITAL MANAGEMENT LLC | $78.941.870 | 999.138 | 1,38% | Aktien |
| Madison Avenue Partners, LP | $73.891.416 | 935.216 | 1,29% | Aktien |
| Boston Trust Walden Corp | $73.637.557 | 932.003 | 1,28% | Aktien |
| ANTIPODES PARTNERS Ltd | $71.581.796 | 905.984 | 1,25% | Aktien |
| Global Alpha Capital Management Ltd. | $67.681.230 | 856.616 | 1,18% | Aktien |
| Vestal Point Capital, LP | $67.158.500 | 850.000 | 1,17% | Aktien |
| VANGUARD GROUP INC | $59.221.500 | 678.290 | 1,03% | Aktien |
| Stephens Investment Management Group LLC | $57.159.864 | 723.451 | 1,00% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $56.575.822 | 716.059 | 0,99% | Aktien |
| Clark Capital Management Group, Inc. | $54.271.890 | 686.899 | 0,95% | Aktien |
| AMERICAN CAPITAL MANAGEMENT INC | $51.599.219 | 653.072 | 0,90% | Aktien |
| ANCHOR CAPITAL ADVISORS LLC | $51.225.201 | 648.338 | 0,89% | Aktien |
| Camber Capital Management LP | $47.216.000 | 800.000 | 0,82% | Aktien |
| Capital World Investors | $46.664.254 | 590.612 | 0,81% | Aktien |
| Artemis Investment Management LLP | $45.305.914 | 573.420 | 0,79% | Aktien |
| Swedbank AB | $41.113.881 | 520.363 | 0,72% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $40.461.021 | 512.100 | 0,71% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $39.194.096 | 496.065 | 0,68% | Aktien |
| Paradice Investment Management LLC | $39.023.513 | 493.906 | 0,68% | Aktien |
| Soleus Capital Management, L.P. | $37.049.527 | 468.922 | 0,65% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $34.953.155 | 442.389 | 0,61% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $34.559.104 | 437.402 | 0,60% | Aktien |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $33.569.453 | 424.876 | 0,59% | Aktien |
| FIRST TRUST ADVISORS LP | $32.942.568 | 416.943 | 0,57% | Aktien |
| FMR LLC | $32.503.608 | 411.386 | 0,57% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $32.370.792 | 409.705 | 0,56% | Aktien |
| Holocene Advisors, LP | $31.598.627 | 399.932 | 0,55% | Aktien |
| Pembroke Management, LTD | $31.513.929 | 398.860 | 0,55% | Aktien |
| GOLDMAN SACHS GROUP INC | $31.286.538 | 395.982 | 0,55% | Aktien |
| Annex Advisory Services, LLC | $30.189.344 | 350.387 | 0,53% | Aktien |
| Bares Capital Management, Inc. | $29.845.058 | 521.129 | 0,52% | Aktien |
| Capital Impact Advisors, LLC | $29.246.895 | 370.167 | 0,51% | Aktien |
| SIRIOS CAPITAL MANAGEMENT L P | $28.050.051 | 355.019 | 0,49% | Aktien |
| Bridgewater Associates, LP | $27.809.466 | 351.974 | 0,49% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $26.754.761 | 338.625 | 0,47% | Aktien |
| Terril Brothers, Inc. | $25.403.295 | 321.520 | 0,44% | Aktien |
| Sio Capital Management, LLC | $23.846.482 | 301.816 | 0,42% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $23.729.389 | 300.334 | 0,41% | Aktien |
| Champlain Investment Partners, LLC | $22.982.271 | 290.878 | 0,40% | Aktien |
| RHUMBLINE ADVISERS | $22.513.223 | 284.942 | 0,39% | Aktien |
| Gotham Asset Management, LLC | $22.364.413 | 283.058 | 0,39% | Aktien |
| UBS Group AG | $22.286.430 | 282.071 | 0,39% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $22.020.640 | 278.707 | 0,38% | Aktien |
| MetLife Investment Management, LLC | $21.771.680 | 275.556 | 0,38% | Aktien |
| Kathmere Capital Management, LLC | $21.450.978 | 271.497 | 0,37% | Aktien |
| Retirement Systems of Alabama | $20.830.354 | 263.642 | 0,36% | Aktien |
| Foresight Group Ltd Liability Partnership | $19.759.724 | 254.030 | 0,34% | Aktien |
| NICHOLAS COMPANY, INC. | $19.699.484 | 249.329 | 0,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $19.524.872 | 247.119 | 0,34% | Aktien |
| Varenne Capital Partners | $18.807.009 | 238.200 | 0,33% | Aktien |
| GLENMEDE TRUST CO NA | $18.639.881 | 235.918 | 0,33% | Aktien |
| Mesirow Institutional Investment Management, Inc. | $18.549.041 | 224.266 | 0,32% | Aktien |
| California Public Employees Retirement System | $18.120.944 | 229.350 | 0,32% | Aktien |
| Woodline Partners LP | $17.906.826 | 226.640 | 0,31% | Aktien |
| Swiss National Bank | $17.862.344 | 226.077 | 0,31% | Aktien |
| Corient Private Wealth LP | $17.322.828 | 219.248 | 0,30% | Aktien |
| GABELLI FUNDS LLC | $16.671.110 | 211.000 | 0,29% | Aktien |
| Lightrock Netherlands B.V. | $16.367.000 | 207.151 | 0,29% | Aktien |
| Sofinnova Investments, Inc. | $15.802.000 | 200.000 | 0,28% | Kaufoption |
| RENAISSANCE TECHNOLOGIES LLC | $15.558.491 | 196.918 | 0,27% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $15.455.225 | 195.611 | 0,27% | Aktien |
| LPL Financial LLC | $15.233.500 | 192.805 | 0,27% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $15.165.574 | 191.945 | 0,26% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $14.032.018 | 177.598 | 0,24% | Aktien |
| Leith Wheeler Investment Counsel Ltd. | $13.821.540 | 174.934 | 0,24% | Aktien |
| BlackRock, Inc. | $13.638.706 | 172.620 | 0,24% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $13.486.770 | 170.697 | 0,24% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $13.455.918 | 160.304 | 0,23% | Aktien |
| Leeward Investments, LLC - MA | $12.983.476 | 164.327 | 0,23% | Aktien |
| Walleye Capital LLC | $12.358.823 | 156.421 | 0,22% | Aktien |
| JANUS HENDERSON GROUP PLC | $12.232.394 | 141.973 | 0,21% | Aktien |
| Bellevue Group AG | $11.543.993 | 146.108 | 0,20% | Aktien |
| Sterling Investment Advisors, Ltd. | $11.379.257 | 144.023 | 0,20% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $11.223.202 | 130.260 | 0,20% | Aktien |
| Defilade Capital Management, L.P. | $11.032.719 | 139.637 | 0,19% | Aktien |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $10.934.984 | 138.400 | 0,19% | Aktien |
| Glenmede Investment Management, LP | $10.909.935 | 190.500 | 0,19% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $10.809.042 | 136.806 | 0,19% | Aktien |
| ALGERT GLOBAL LLC | $10.560.477 | 133.660 | 0,18% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $10.209.435 | 129.217 | 0,18% | Aktien |
| ArrowMark Colorado Holdings LLC | $9.102.268 | 115.204 | 0,16% | Aktien |
| STRS OHIO | $8.815.936 | 111.580 | 0,15% | Aktien |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $8.503.609 | 107.627 | 0,15% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $8.430.130 | 106.697 | 0,15% | Aktien |
Unternehmensinsider 22 Insider · 11 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 21. Januar 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 23. Januar 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 27. Januar 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 21. Januar 2026 A | 0 | 0 | 2 | $-2.032.133 |
| Richard A Baron | Senior VP and CFO | 2. Mai 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 7. März 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 25. Februar 2026 M | 0 | 0 | 3 | $-3.441.700 |
| David C Paul | Executive Chairman | 21. Januar 2026 A | 60.417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 1. Februar 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 25. Juni 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2. Februar 2018 A | 35.217 | 0 | 0 | $0 |
| Stephen T Zarrilli | Direktor | 18. August 2026 M | 0 | 0 | 2 | $-4.283.250 |
| David D Davidar | Direktor | 27. Juli 2026 G | 507.675 | 0 | 2 | $-4.169.000 |
| Ann D Rhoads | Direktor | 4. Juni 2026 M | 40.384 | 0 | 3 | $-1.402.600 |
| Dan Wolterman | Direktor | 21. Januar 2026 A | 24.025 | 0 | 0 | $0 |
| Leslie V Norwalk | Direktor | 21. Januar 2026 A | 10.419 | 0 | 2 | $-557.600 |
| Dan Lemaitre | Direktor | 21. Januar 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | Direktor | 21. Januar 2026 A | 15.578 | 0 | 0 | $0 |
| Robert Andrew Douglas | Direktor | 21. Januar 2026 A | 2.005 | 0 | 0 | $0 |
| James R Tobin | Direktor | 21. Januar 2026 A | 0 | 0 | 0 | $0 |
| Kurt Wheeler | Direktor | 22. Januar 2019 A | 44.319 | 0 | 0 | $0 |
| Robert Liptak | Direktor | 22. Januar 2019 A | 26.159 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 100 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2,27% | 219.621 NS | 30. April 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 2,04% | 118.993 SH | 19. August 2026 | Täglich |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,86% | 10.979 NS | 30. April 2026 | N-PORT |
| FFOX · FundX Investment Trust | 1,82% | 55.470 NS | 30. Juni 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,53% | 21.591 NS | 30. April 2026 | N-PORT |
| IHI · iShares Trust | 1,35% | 534.779 SH | 19. August 2026 | Täglich |
| LFSC · RBB Fund, Inc. | 1,27% | 16.258 NS | 31. Mai 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,24% | 242.837 NS | 30. April 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,91% | 37.413 SH | 19. August 2026 | Täglich |
| DTEC · ALPS ETF Trust | 0,87% | 7.891 NS | 31. Mai 2026 | N-PORT |
| TAX · EA Series Trust | 0,86% | 2.682 NS | 29. Mai 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,83% | 1.408 NS | 30. April 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 0,82% | 90 NS | 30. April 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,55% | 31.832 NS | 30. April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,54% | 2.130 NS | 31. Mai 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,54% | 11.834 SH | 19. August 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,47% | 111.810 SH | 19. August 2026 | Täglich |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,39% | 2.462 NS | 31. Mai 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 18.545 NS | 30. April 2026 | N-PORT |
| GQQQ · EA Series Trust | 0,34% | 5.950 NS | 29. Mai 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,31% | 21.679 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,31% | 35.610 SH | 19. August 2026 | Täglich |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,30% | 15.061 SH | 19. August 2026 | Täglich |
| PTMC · Pacer Funds Trust | 0,29% | 12.781 NS | 30. April 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,29% | 42.239 NS | 30. April 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,29% | 3.969 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,28% | 26.195 NS | 31. Mai 2026 | N-PORT |
| ANEW · ProShares Trust | 0,26% | 244 NS | 31. Mai 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 183.180 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,24% | 1.499.816 SH | 19. August 2026 | Täglich |
| CLSE · Trust for Professional Managers | 0,23% | 17.617 NS | 31. Mai 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,22% | 5.809 NS | 31. Mai 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,21% | 56.008 NS | 30. April 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 46.648 NS | 30. April 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,20% | 1.845 NS | 30. April 2026 | N-PORT |
| MVV · ProShares Trust | 0,20% | 3.849 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,19% | 535.955 NS | 31. Mai 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,17% | 2.091 NS | 31. Mai 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,17% | 300.905 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,16% | 8.751 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,16% | 51.771 NS | 30. April 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 7.980 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,15% | 66.265 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | 0,15% | 5.059 SH | 19. August 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,15% | 4.563 NS | 30. April 2026 | N-PORT |
| UMDD · ProShares Trust | 0,14% | 538 NS | 31. Mai 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,13% | 20.408 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,13% | 338.547 SH | 19. August 2026 | Täglich |
| SMMD · iShares Trust | 0,13% | 56.581 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,13% | 199.853 NS | 30. April 2026 | N-PORT |